Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunome Inc.

16.07
+0.09000.56%
Post-market: 16.070.00000.00%19:58 EDT
Volume:732.92K
Turnover:11.79M
Market Cap:1.40B
PE:-5.47
High:16.44
Open:15.93
Low:15.64
Close:15.98
52wk High:17.32
52wk Low:5.15
Shares:87.05M
Float Shares:70.81M
Volume Ratio:0.75
T/O Rate:1.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9374
EPS(LYR):-4.9960
ROE:-81.20%
ROA:-40.20%
PB:5.19
PE(LYR):-3.22

Loading ...

Immunome Inc. Announces Inducement Grants of Stock Options to New Employees Under 2024 Plan

Reuters
·
Sep 05

Immunome Price Target Maintained With a $25.00/Share by Guggenheim

Dow Jones
·
Aug 25

Immunome Initiated at Outperform by Evercore ISI Group

Dow Jones
·
Aug 23

BUZZ-Barclays cuts Merck to 'equal weight', cites multiple risks ahead of CMD

Reuters
·
Aug 19

Immunome Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 11

Immunome Q2 EPS $(0.50) Beats $(0.55) Estimate, Sales $4.015M May Not Be Comparable To $714.286K Estimate

Benzinga
·
Aug 07

Immunome Inc. Announces Inducement Grants with Stock Options for New Employees Under 2024 Plan

Reuters
·
Aug 02

argenx Reports Half Year 2025 Financial Results and Provides Second Quarter Business Update

GlobeNewswire
·
Jul 31

Immunome Inc. Announces Inducement Grants with Stock Options for New Employees Under 2024 Plan

Reuters
·
Jul 04

Immunome Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 12

BRIEF-Immunome Reports Inducement Grants Under Nasdaq Listing Rule

Reuters
·
Jun 06

Immunome Inc. Announces Inducement Grants for New Employees Under 2024 Plan

Reuters
·
Jun 06

Jean Jacques Bienaime, Director, Reports Acquisition of Common Shares in Immunome Inc

Reuters
·
Jun 04

Sector Update: Health Care Stocks Softer Friday Afternoon

MT Newswires Live
·
May 24

Wedbush Adjusts Price Target on Immunome to $21 From $33, Maintains Outperform Rating

MT Newswires Live
·
May 13

Immunome Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

BRIEF-Immunome Q1 Income From Operations USD -44.636 Million

Reuters
·
May 13

Immunome Q1 EPS $(0.52) Beats $(0.68) Estimate, Sales $2.93M Beat $285.71K Estimate

Benzinga
·
May 13

Immunome Inc. Reports Q1 2025 Net Loss of $41.6 Million Despite Strong Cash Position

Reuters
·
May 13